| Literature DB >> 3815982 |
B L Shulkin, B Shapiro, I R Francis, R Dorr, S W Shen, J C Sisson.
Abstract
I-131 metaiodobenzylguanidine (I-131 MIBG) is a well established imaging agent that reliably detects pheochromocytoma. In some patients, however, I-131 MIBG may fail to localize pheochromocytoma. I-123 MIBG has several potential advantages over I-131 MIBG, and these advantages may enable locating pheochromocytomas which have eluded other techniques, including I-131 MIBG imaging. A patient with primary extra-adrenal pheochromocytoma is described who illustrates the superiority of I-123 MIBG for the imaging of pheochromocytoma.Entities:
Mesh:
Substances:
Year: 1986 PMID: 3815982 DOI: 10.1097/00003072-198612000-00012
Source DB: PubMed Journal: Clin Nucl Med ISSN: 0363-9762 Impact factor: 7.794